On July 6, Quantinuum rose 6.37% in regular trading, trading at $79.25 per share, with turnover of approximately $37.97 million.

On the news front, the stock has experienced persistent wide-ranging swings since multiple top-tier Wall Street investment banks simultaneously initiated coverage on June 29. The massive gap between target prices — ranging from Morgan Stanley's $78 (Equalweight) to Rosenblatt's $155 (Buy) — reflects a fundamental disagreement over the quantum computing sector's commercialization trajectory. Other notable initiations include JPMorgan at Overweight with a $97 target, BofA Securities at Buy with $100, UBS at Buy with $93, Mizuho at Outperform with $90, Jefferies at Buy with $90, and Cantor Fitzgerald at Overweight with $90. The nearly 2x spread between the highest and lowest targets has left the market without a consensus valuation anchor, resulting in elevated volatility as the stock oscillates between bullish and bearish positioning.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)